One-Step Cow Ovulation Rapid Test

SARS-CoV-2 Rapid Antigen Test kit
Colloidal Gold Method Medical
Simple Rapid
Convenient
Sensitivity : 98.4%
Specificity : 98.1%
Test Time : 10-15min

Covid-19 Self Test Kit

We are the authorized first vendor of ADTech!
KFDA CE approved,
FDA Pending
Price : Negotiable


Pre-Clinical Test Report
Accuracy
- In total samples 93.3% (14/15) - In positive samples 91.7% (11/12)

1. Pre-Clinical Test summary

1) Pre-clinical test is fulfilled by Domestic large clinical laboratory with ADTech COVID-19 IgM/IgG RAPID KIT
2) Tests are made by total 15 samples with 12 positive and 3 negative samples
3) Clinical Laboratory tested the sample with Immunofluorescence Analysis


2. Pre-clinical test result

1) Samples were tested by ADTech COVID-19 IgM/IgG RAPID KIT
2) Test result by ADTechs RAPID KIT
- 4 negatives and 11 positives results in 15 samples
3) Comparison between Immunofluorescence analysis and ADTechs RAPID KIT
- 14 test results are same(including negative and positive results) - 1 samples test result are different(Positive Negative by ADTech

For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.

1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.

Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box

Saliva Test Kit Painless testing plastic disposable Ag Rapid Detection Kit

Antibody Test Kits Hot Sale Medical Diagnostic Antigen Antibody Rapid Test Kits

COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains:
GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request.

To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away.
1. Nasopharyngeal
2. Nasal
3. Saliva

Price and Minumum Quantity
Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces
Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet
Sample: Available. Sample Cost Born By Supplier
Product Model And Origin
Brand: GENEDIAModel: 643G-S (Saliva)
Seller Code: Genedia w covid 19 agHS Code: 3002.15
Standards: Ce
Competitive Advantages
Allow wider testing with fast test time (10 minutes)
All necessary materials provided / no equipment needed
Sensitivity: 93.33%, specificity: 100%
Free sample. no moq. price is negotiable. customized packing.
Other Details
20 tests / kit
24 months from the date of manufacture
2 ~ 30c(35.6 ~ 86f) available for room temperature deliver
In stock. fast delivery.
1 x Instructions for Use Manual
40 x Test Cassettes
1 x Buffer
40 x Dropper

Covd-19 IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) is a solid phase immunochromatographic assay for the rapid, qualitative and dierential detection of IgG and IgM antibodies to 2019 Novel Corona Virus in human whole blood, serum or plasma.



Specification.jpg

Product: Rapid Diagnostic Test Kit

Item: Corona Virus Test Kit

Specimen: Whole Blood/Serum/Plasma

Format: Strip/Cassette

Port of Loading: Shanghai

OEM and ODM: OEM/ODM Welcome

Shipping: By UPS, FEDEX, DHL, TNT, by air or by sea

MOQ for Private label: Low MOQ 1600 boxes, Please contact us.

Note: Store this product in a cool and dry place, avoid direct sunlight, stay away from places that children can contact, and avoid eye contact. If you have allergies to this product, please stop using and consult a doctor.

COVID-19 Corona Virus Rapid Test Kit11.pngCOVID-19 Corona Virus Rapid Test Kit12.png

Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.

Price and Minumum Quantity
Price FOB in USD: NegotiableMinimum Order Qty: 10000
Production Capacity: 1000000Packaging: 25 Persons/box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: Easysweet
HS Code: 3822009020
Standards: Ce
Competitive Advantages
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Other Details
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)

Access Bio Care Start Covid-19 Rapid Antigen Test Kit

Product Details:
Number of Reactions(Preps) per Kit : 1
Brand : Access Bio
Test Method : Antigen Test
Result Time (Rapid Kits) : 10 min
Sample Type ; Nasal Swab
Packaging Size : 20 Test Kits/Box
Packaging Type : Box
The CareStart COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between